Note: Advance registration for Satellite Programs is not available to industry professionals. Industry professionals may register on-site for symposia on a first-come, first-served basis. Satellite programs offer sponsors the opportunity to provide professional attendees with comprehensive insights into important interventional topics and issues facing today's interventional specialists. The satellite programs schedule is comprised of Breakfast Meetings, Presentation Theater Programs (lunch sessions) and Evening Programs.
John joins Amgen from Bristol-Myers Squibb (BMS), where he served as the global head of Clinical Development for marketed products as well as global clinical operations. Earlier roles at BMS included head of worldwide Medical and as a full development team lead in oncology. In these roles, John led a number of innovative changes to the company’s development and medical organizations and practices. He also served as chief medical officer, Europe, head of . Medical and vice president of Cardiovascular Medical. Prior to joining BMS, he was cardiovascular group leader at Pfizer, and was a member of the faculty staff at Kaiser Hospital in San Francisco.
During the quarterly meeting of the USPTO’s Patent Public Advisory Committee (PPAC), Chief Financial Officer TONY SCARDINO reported that the 2014 appropriations bill signed in January funds the USPTO at $ billion – $ million above the fiscal 2013 enacted level and $ million above the fiscal 2013 sequestration level. The budget will allow the USPTO to hire 1,000 patent examiners and 63 administrative patent judges and provides funding related to opening satellite offices in San Jose, Denver, and Dallas. Projected 2014 spending is estimated at $ billion. The White House will release its fiscal 2015 budget on March 4.